期刊文献+

4-甲基哌嗪-1-二硫代甲酸-(3-氰基-3,3-二苯基)丙酯盐酸盐在小鼠的抗肿瘤作用 被引量:4

Antitumor effect of hydrochloride 4-methyl-piperazine-1-carbodithioc acid 3-cyano-3,3-diphenyl-propyl ester
下载PDF
导出
摘要 目的 :观察 4 甲基哌嗪 1 二硫代甲酸 (3 氰基 3,3 二苯基 )丙酯盐酸盐 (Hyd)对小鼠移植性肿瘤的抑制作用 ,以确定该化合物的应用前景。方法 :采用小鼠肉瘤 180和肝癌 2 2及人胃癌异种移植裸鼠肿瘤模型 ,观察Hyd对小鼠移植性肿瘤生长的影响。结果 :通过口服灌胃给药 ,不同浓度Hyd对小鼠移植性肉瘤S180 抑制率可达到 4 6 .4 %~ 5 9.6 % (P <0 .0 1~ 0 .0 0 1) ;对小鼠移植性肝癌H2 2 抑制率可达到39 .3%~ 5 1.6 % (P <0 .0 5~ 0 .0 0 1) ;对裸鼠人胃癌异种移植瘤的抑制率可达到 18.1%~ 5 9.0 %。结论 :Hyd对小鼠移植性肝癌H2 2 和小鼠移植性肉瘤S180 有明显抑制作用 。 AIM: To study the inhibition effects of the hydrochloride 4 methyl piperazine 1 carbodithioc acid 3 cyano 3,3 diphenyl propyl ester (Hyd) on the growth of transplant carcinoma in mice. METHODS: The growth of tumor was observed by models of transplant tumor in mice. RESULTS: The inhibition rates of Hyd against tumor growth of S 180 and H 22 implanted human gastric carcinoma were 46.4 %- 59.6 %, 39.3 %- 51.6 % and 18.1 %- 59.0 %, respectively in nude mice. CONCLUSION: Hyd can inhibit the growth of transplanted hepatocyte carcinoma 22, sarcoma 180 in mice, and implanted human gastric carcinoma in mice and nude mice.
出处 《中国临床药理学与治疗学》 CAS CSCD 2004年第1期59-62,共4页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 国家自然基金资助项目 (№ 2 0 172 0 0 6) 国家重点科技项目 (№ 96 90 1 0 2 0 8)
关键词 4-甲基哌嗪-1-二硫代甲酸-(3-氰基-3-3-二苯基)丙酯盐酸盐 肉瘤S180 肝癌H22 人胃癌异种移植性肿瘤 hydrochloride 4-methyl-piperazine-1-carbodithioc acid 3-cyano-3,3-diphenyl-propyl ester sarcoma 180 hepatocyte carcinoma 22 implanted human gastric carcinoma
  • 相关文献

参考文献1

二级参考文献6

  • 1Li R T,Synth Commun,1998年,28卷,2期,295页
  • 2Gerhauser C,Cancer Res,1997年,57卷,2期,272页
  • 3Ge Z M,Eur J Med Chem
  • 4Ge Z M,Synth Commun,1999年,29卷,18期,3191页
  • 5Li R T,Synth Commun,1999年,29卷,1期,65页
  • 6Li R T,高等学校化学学报,1999年,20卷,12期,1897页

共引文献5

同被引文献128

  • 1姜小梅,凌笑梅,李润涛,崔景荣.HPLC-ESI/ITMS^n法分析大鼠体内4-甲基哌嗪-1-二硫代甲酸-(3-氰基-3,3-二苯基)丙酯盐酸盐及其主要代谢物[J].药学学报,2006,41(11):1084-1089. 被引量:3
  • 2Reisinger EC,Kern P,Ernst M,et al.Inhibition of HIV progression by dithiocarbamate.Lancet,1990,335(8691):679.
  • 3Gandara DR,Perez EA,Weibe V,et al.Cisplatin chemoprotection and rescue:pharmacologic modulation of toxicity.Semin Oncol,1991,18(S3):49.
  • 4Moellering D,Mcandrew J,Jo H,et al.Effects of pyrrolidine dithiocarbamate on endothelial cells:protecting against oxidative stress.Free Radic Biol Med,1999,26(9-10):1138.
  • 5Yoshida A,Yoshida S,Ishibashi T,et al.Suppression of retinal neovascularization by the NF-kB inhibitor pyrrolidine dithiocarbamate in mice.Invest Opthalmol Visual Sci,1999,40(7):1624.
  • 6Gerhauser C,You M,Liu JF,et al.Cancer chemopreventive potential of sulforamate,a novel analogue of sulforaphane that induce phase.drug metabolizing enzymes.Cancer Res,1997,57:272.
  • 7GUOBao-guo(郭保国) GEZe-mei(葛泽梅) CHENGTie-min(程铁民) etal.Synthesis and anti-tumor activity of 1 4-bis piperazine derivatives(1 4-二 哌嗪类化合物的合成及其抗肿瘤活性)[J].Acta Pharm Sin,2001,36(3):185-185.
  • 8Ge ZM,Li RT,Cheng TM,et al.Synthesis and biological activities of dipiperazinium salts containing dithiocarboxyl.Arch Pharm Med Chem,2001,334(5):173.
  • 9Li RT,Cheng TM,Cui JR,et al.Study synthesis and activity of dithiocarbamate.US Pat:1328999,2002-01.
  • 10Li RT,Cheng TM,Cui JR,et al.Piperazine mono(dithio)-carbamate ester compounds and analog:preparation method and pharmaceutical use.US Pat:20/157733,2002-05; WO Apply NO:PCT/US02/16772,2002-5.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部